Plasma AGE and Oxidation Products, Renal Function, and Preeclampsia in Pregnant Women with Type 1 Diabetes: A Prospective Observational Study

Table 4

Plasma concentrations of circulating advance glycation end products and oxidation products, during gestation and prior to the onset of preeclampsia.

		DM+PE+ ()	value	DM+PE- ()	value^#	DM- ()
CML	V1		0.45		0.42
	V2		0.91		0.10
	V3		0.45		0.39
CEL	V1		0.33		0.93
	V2		0.38		0.36
	V3		0.92		0.015
MGH1	V1		0.22		0.36
	V2		0.63		0.24
	V3		0.25		0.040
3DGH	V1		0.20		0.69
	V2		0.29		0.07
	V3		0.72		0.14
GH1	V1		0.042		0.12
	V2		0.43		0.68
	V3		0.91		0.20
MetSO	V1		0.92		0.24
	V2		0.60		0.10
	V3		0.82		0.15
2-AAA	V1		0.47		0.48
	V2		0.47		0.024
	V3		0.89		0.07

Data are presented as . Each AGE and oxidation product is corrected by total protein concentration. Units for all: nmol/g. Independent sample tests were used as appropriate. Boldface indicates values < 0.05 (statistically significant). value, DM+PE- vs. DM+PE+. ^# value, DM+PE- vs. DM-.